Stereotaxis, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Stereotaxis, Inc. on January 22, 2016, reporting an event that occurred on January 20, 2016. The filing addresses a regulatory notice received from the Nasdaq Stock Market regarding the company's compliance with listing standards.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on stock price performance relative to listing rules.
Material Changes
The primary material event is the notification from Nasdaq that the company failed to comply with Rule 5550(a)(2), the Minimum Bid Price Rule. This failure occurred because the bid price of the company's common stock closed below $1.00 per share for 30 consecutive business days prior to January 20, 2016.
Outlook, Risks, and Contingencies
- Compliance Period: The company has been granted 180 calendar days, until July 18, 2016, to regain compliance.
- Compliance Requirement: To regain compliance, the bid price must close at $1.00 per share or more for a minimum of 10 consecutive business days before the July 18, 2016 deadline.
- Delisting Risk: If compliance is not demonstrated by the deadline and the company is not eligible for an additional 180-day period, Nasdaq will notify the company that the stock is subject to delisting.
- Appeal Rights: The company retains the right to appeal a delisting determination if it occurs.
Key Facts for Investor Verification
- Verify the current trading price of Stereotaxis common stock to assess the likelihood of meeting the $1.00 threshold.
- Monitor the company's stock performance over the next 10 consecutive business days to determine if the initial compliance window is met.
- Review future filings to confirm if the company secures an additional 180-day compliance period or if a delisting notice is issued after July 18, 2016.
- Check for any stock split announcements, which are a common corporate action used to address minimum bid price deficiencies.